Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient
: In this report, we describe a case of Rhodococcus equi lung infection diagnosed in an allogeneic hematopoietic stem cell transplant with oral graft‐versus‐host disease 3 months after stem cell infusion. The lung lesion persisted despite an approximate 3 months of vancomycin therapy, but then respo...
Gespeichert in:
Veröffentlicht in: | Transplant infectious disease 2008-02, Vol.10 (1), p.48-51 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 51 |
---|---|
container_issue | 1 |
container_start_page | 48 |
container_title | Transplant infectious disease |
container_volume | 10 |
creator | Cronin, S.M. Abidi, M.H. Shearer, C.J. Chandrasekar, P.H. Ibrahim, R.B. |
description | : In this report, we describe a case of Rhodococcus equi lung infection diagnosed in an allogeneic hematopoietic stem cell transplant with oral graft‐versus‐host disease 3 months after stem cell infusion. The lung lesion persisted despite an approximate 3 months of vancomycin therapy, but then responded favorably to a combination of intravenous ertapenem at 1 g daily and oral rifampin at 600 mg daily for 1 month. An overview of Rhodococcus infection in transplant recipients is presented. This case and the discussed literature suggest that combination antibiotic therapy is warranted in patients with decreased humoral and cellular immunity. |
doi_str_mv | 10.1111/j.1399-3062.2007.00274.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70273816</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70273816</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3664-9919f59afb87451433900ee7c32aaf4ba30621c4515c29b3c1c56afd718561643</originalsourceid><addsrcrecordid>eNqNkE1LxDAQhoMoun78BcnJW2vSpE0DXsTPBUGQ9SghzU41S9rUpsX135vuLno1DOQN885M5kEIU5LSeC5XKWVSJowUWZoRIlJCMsHT9R6a_Sb2N7pMskywI3QcwooQKiSXh-iICkE5Z-UMvb18-KU33pgxYPgcLXZj-45tW4MZrG-jwjqGc_4dWrAGf0CjB995C0N8hQEabMA5PPS6DZ3T7YB7MLaz0A6n6KDWLsDZ7j5Br_d3i5vH5On5YX5z_ZQYVhQ8kZLKOpe6rkrBc8oZk4QACMMyrWte6WkfamIqN5msmKEmL3S9FLTMC1pwdoIutn273n-OEAbV2DD9Srfgx6BExMNKWkRjuTWa3ofQQ6263ja6_1aUqAmtWqmJoJomqgmt2qBV61h6vpsxVg0s_wp3LKPhamv4sg6-_91YLea3UbAfbtaH7w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70273816</pqid></control><display><type>article</type><title>Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Cronin, S.M. ; Abidi, M.H. ; Shearer, C.J. ; Chandrasekar, P.H. ; Ibrahim, R.B.</creator><creatorcontrib>Cronin, S.M. ; Abidi, M.H. ; Shearer, C.J. ; Chandrasekar, P.H. ; Ibrahim, R.B.</creatorcontrib><description>: In this report, we describe a case of Rhodococcus equi lung infection diagnosed in an allogeneic hematopoietic stem cell transplant with oral graft‐versus‐host disease 3 months after stem cell infusion. The lung lesion persisted despite an approximate 3 months of vancomycin therapy, but then responded favorably to a combination of intravenous ertapenem at 1 g daily and oral rifampin at 600 mg daily for 1 month. An overview of Rhodococcus infection in transplant recipients is presented. This case and the discussed literature suggest that combination antibiotic therapy is warranted in patients with decreased humoral and cellular immunity.</description><identifier>ISSN: 1398-2273</identifier><identifier>EISSN: 1399-3062</identifier><identifier>DOI: 10.1111/j.1399-3062.2007.00274.x</identifier><identifier>PMID: 17714438</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Actinomycetales Infections - diagnostic imaging ; Actinomycetales Infections - microbiology ; allogeneic ; Anti-Bacterial Agents - therapeutic use ; antibiotics ; beta-Lactams - therapeutic use ; combination ; Drug Therapy, Combination ; Graft vs Host Disease - complications ; graft‐versus‐host‐disease ; Hematopoietic Stem Cell Transplantation - adverse effects ; Humans ; Lung Diseases - diagnostic imaging ; Lung Diseases - microbiology ; Male ; Middle Aged ; Radiography ; Rhodococcus ; Rhodococcus equi - isolation & purification ; Rifampin - therapeutic use ; stem cell ; transplant ; Transplantation, Homologous - adverse effects</subject><ispartof>Transplant infectious disease, 2008-02, Vol.10 (1), p.48-51</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3664-9919f59afb87451433900ee7c32aaf4ba30621c4515c29b3c1c56afd718561643</citedby><cites>FETCH-LOGICAL-c3664-9919f59afb87451433900ee7c32aaf4ba30621c4515c29b3c1c56afd718561643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1399-3062.2007.00274.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1399-3062.2007.00274.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17714438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cronin, S.M.</creatorcontrib><creatorcontrib>Abidi, M.H.</creatorcontrib><creatorcontrib>Shearer, C.J.</creatorcontrib><creatorcontrib>Chandrasekar, P.H.</creatorcontrib><creatorcontrib>Ibrahim, R.B.</creatorcontrib><title>Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient</title><title>Transplant infectious disease</title><addtitle>Transpl Infect Dis</addtitle><description>: In this report, we describe a case of Rhodococcus equi lung infection diagnosed in an allogeneic hematopoietic stem cell transplant with oral graft‐versus‐host disease 3 months after stem cell infusion. The lung lesion persisted despite an approximate 3 months of vancomycin therapy, but then responded favorably to a combination of intravenous ertapenem at 1 g daily and oral rifampin at 600 mg daily for 1 month. An overview of Rhodococcus infection in transplant recipients is presented. This case and the discussed literature suggest that combination antibiotic therapy is warranted in patients with decreased humoral and cellular immunity.</description><subject>Actinomycetales Infections - diagnostic imaging</subject><subject>Actinomycetales Infections - microbiology</subject><subject>allogeneic</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>antibiotics</subject><subject>beta-Lactams - therapeutic use</subject><subject>combination</subject><subject>Drug Therapy, Combination</subject><subject>Graft vs Host Disease - complications</subject><subject>graft‐versus‐host‐disease</subject><subject>Hematopoietic Stem Cell Transplantation - adverse effects</subject><subject>Humans</subject><subject>Lung Diseases - diagnostic imaging</subject><subject>Lung Diseases - microbiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Radiography</subject><subject>Rhodococcus</subject><subject>Rhodococcus equi - isolation & purification</subject><subject>Rifampin - therapeutic use</subject><subject>stem cell</subject><subject>transplant</subject><subject>Transplantation, Homologous - adverse effects</subject><issn>1398-2273</issn><issn>1399-3062</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1LxDAQhoMoun78BcnJW2vSpE0DXsTPBUGQ9SghzU41S9rUpsX135vuLno1DOQN885M5kEIU5LSeC5XKWVSJowUWZoRIlJCMsHT9R6a_Sb2N7pMskywI3QcwooQKiSXh-iICkE5Z-UMvb18-KU33pgxYPgcLXZj-45tW4MZrG-jwjqGc_4dWrAGf0CjB995C0N8hQEabMA5PPS6DZ3T7YB7MLaz0A6n6KDWLsDZ7j5Br_d3i5vH5On5YX5z_ZQYVhQ8kZLKOpe6rkrBc8oZk4QACMMyrWte6WkfamIqN5msmKEmL3S9FLTMC1pwdoIutn273n-OEAbV2DD9Srfgx6BExMNKWkRjuTWa3ofQQ6263ja6_1aUqAmtWqmJoJomqgmt2qBV61h6vpsxVg0s_wp3LKPhamv4sg6-_91YLea3UbAfbtaH7w</recordid><startdate>200802</startdate><enddate>200802</enddate><creator>Cronin, S.M.</creator><creator>Abidi, M.H.</creator><creator>Shearer, C.J.</creator><creator>Chandrasekar, P.H.</creator><creator>Ibrahim, R.B.</creator><general>Blackwell Publishing Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200802</creationdate><title>Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient</title><author>Cronin, S.M. ; Abidi, M.H. ; Shearer, C.J. ; Chandrasekar, P.H. ; Ibrahim, R.B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3664-9919f59afb87451433900ee7c32aaf4ba30621c4515c29b3c1c56afd718561643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Actinomycetales Infections - diagnostic imaging</topic><topic>Actinomycetales Infections - microbiology</topic><topic>allogeneic</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>antibiotics</topic><topic>beta-Lactams - therapeutic use</topic><topic>combination</topic><topic>Drug Therapy, Combination</topic><topic>Graft vs Host Disease - complications</topic><topic>graft‐versus‐host‐disease</topic><topic>Hematopoietic Stem Cell Transplantation - adverse effects</topic><topic>Humans</topic><topic>Lung Diseases - diagnostic imaging</topic><topic>Lung Diseases - microbiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Radiography</topic><topic>Rhodococcus</topic><topic>Rhodococcus equi - isolation & purification</topic><topic>Rifampin - therapeutic use</topic><topic>stem cell</topic><topic>transplant</topic><topic>Transplantation, Homologous - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cronin, S.M.</creatorcontrib><creatorcontrib>Abidi, M.H.</creatorcontrib><creatorcontrib>Shearer, C.J.</creatorcontrib><creatorcontrib>Chandrasekar, P.H.</creatorcontrib><creatorcontrib>Ibrahim, R.B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplant infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cronin, S.M.</au><au>Abidi, M.H.</au><au>Shearer, C.J.</au><au>Chandrasekar, P.H.</au><au>Ibrahim, R.B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient</atitle><jtitle>Transplant infectious disease</jtitle><addtitle>Transpl Infect Dis</addtitle><date>2008-02</date><risdate>2008</risdate><volume>10</volume><issue>1</issue><spage>48</spage><epage>51</epage><pages>48-51</pages><issn>1398-2273</issn><eissn>1399-3062</eissn><abstract>: In this report, we describe a case of Rhodococcus equi lung infection diagnosed in an allogeneic hematopoietic stem cell transplant with oral graft‐versus‐host disease 3 months after stem cell infusion. The lung lesion persisted despite an approximate 3 months of vancomycin therapy, but then responded favorably to a combination of intravenous ertapenem at 1 g daily and oral rifampin at 600 mg daily for 1 month. An overview of Rhodococcus infection in transplant recipients is presented. This case and the discussed literature suggest that combination antibiotic therapy is warranted in patients with decreased humoral and cellular immunity.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>17714438</pmid><doi>10.1111/j.1399-3062.2007.00274.x</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1398-2273 |
ispartof | Transplant infectious disease, 2008-02, Vol.10 (1), p.48-51 |
issn | 1398-2273 1399-3062 |
language | eng |
recordid | cdi_proquest_miscellaneous_70273816 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Actinomycetales Infections - diagnostic imaging Actinomycetales Infections - microbiology allogeneic Anti-Bacterial Agents - therapeutic use antibiotics beta-Lactams - therapeutic use combination Drug Therapy, Combination Graft vs Host Disease - complications graft‐versus‐host‐disease Hematopoietic Stem Cell Transplantation - adverse effects Humans Lung Diseases - diagnostic imaging Lung Diseases - microbiology Male Middle Aged Radiography Rhodococcus Rhodococcus equi - isolation & purification Rifampin - therapeutic use stem cell transplant Transplantation, Homologous - adverse effects |
title | Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T02%3A08%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rhodococcus%20equi%20lung%20infection%20in%20an%20allogeneic%20hematopoietic%20stem%20cell%20transplant%20recipient&rft.jtitle=Transplant%20infectious%20disease&rft.au=Cronin,%20S.M.&rft.date=2008-02&rft.volume=10&rft.issue=1&rft.spage=48&rft.epage=51&rft.pages=48-51&rft.issn=1398-2273&rft.eissn=1399-3062&rft_id=info:doi/10.1111/j.1399-3062.2007.00274.x&rft_dat=%3Cproquest_cross%3E70273816%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70273816&rft_id=info:pmid/17714438&rfr_iscdi=true |